SKELETAL ADVERSE EVENTS ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS: EMERGING TRENDS FROM THE US FOOD AND DRUG ADMINISTRATION ADVERSE EVENT REPORTING SYSTEM

被引：0
|
作者：
Pundole, X. [1 ]
Sarangdhar, M. [2 ]
Suarez-Almazor, M. E. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN259
引用
收藏
页码：S486 / S486
页数：1
相关论文
共 50 条
  • [11] Adverse Events Associated with Use of Digoxin Immune Fab Reported to the US Food and Drug Administration Adverse Event Reporting System, 1986-2019
    Wei, Shaokui
    Niu, Manette T.
    Dores, Graca M.
    [J]. DRUGS-REAL WORLD OUTCOMES, 2021, 8 (02) : 253 - 262
  • [12] Mortality and adverse events with brand and generic clopidogrel in the US Food and Drug Administration Adverse Event Reporting System
    Serebruany, Victor L.
    Hall, Trygve S.
    Atar, Dan
    Agewall, Stefan
    Kim, Moo Hyun
    Geudelin, Bernard
    Lomakin, Nikita
    Marciniak, Thomas A.
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2019, 5 (04) : 210 - 215
  • [13] Thromboembolic events associated with immune checkpoint inhibitors: A real-world study of data from the food and drug administration adverse event reporting system (FAERS) database
    Li, Hao
    Sun, Ximu
    Sun, Dan
    Zhao, Jin
    Xu, Zhouming
    Zhao, Peng
    Ma, Zhuo
    Zhang, Yuhui
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 98
  • [14] Vitiligo adverse events and associated medications as reported in the US Food and Drug Administration's Adverse Event Reporting System from 2016 to 2021
    Learned, Christine
    Cohen, Stephanie R.
    Alsukait, Sarah
    Deverapalli, Sandhya
    Rosmarin, David
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (01) : 197 - 199
  • [15] Arrhythmic events associated with immune checkpoint inhibitors therapy: A real-world study based on the Food and Drug Administration Adverse Event Reporting System database
    Liu, Yunwei
    Chen, Yanxin
    Zeng, Zhimin
    Liu, Anwen
    [J]. CANCER MEDICINE, 2023, 12 (06): : 6637 - 6648
  • [16] A pharmacovigilance study of adverse events associated with polymyxins based on the US Food and Drug Administration Adverse Event Reporting System (FAERS) database
    Wu, Tingxi
    Shi, Yanfeng
    Xu, Chang
    Zhu, Bin
    Li, Dandan
    Li, Zhe
    Zhao, Zhigang
    Zhang, Yang
    [J]. EXPERT OPINION ON DRUG SAFETY, 2024,
  • [17] Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system
    Zhai, Yinghong
    Ye, Xiaofei
    Hu, Fangyuan
    Xu, Jinfang
    Guo, Xiaojing
    Zhuang, Yonglong
    He, Jia
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01)
  • [18] Detection and analysis of signals of adverse events of memantine based on the US food and drug administration adverse event reporting system
    Zhang, Weichui
    Chen, Mianhai
    Cai, Xiaolin
    Zhang, Mengting
    Hu, Mianda
    Hu, Yanghui
    Yang, Yurong
    Zhu, Jinfeng
    Du, Yikuan
    Yang, Chun
    [J]. EXPERT OPINION ON DRUG SAFETY, 2024, 23 (05) : 617 - 625
  • [19] Immune checkpoint inhibitor-associated electrolyte disorders: query of the Food and Drug Administration Adverse Event Reporting System
    Wanchoo, Rimda
    Sakhiya, Vipulbhai
    Jhaveri, Kenar D.
    [J]. KIDNEY INTERNATIONAL, 2021, 100 (04) : 945 - 947
  • [20] Severe cutaneous adverse reactions associated with the immune checkpoint inhibitors: A case/non-case analysis using the Food and Drug Administration Adverse Event Reporting System
    Godfrey, Hannah
    Jedlowski, Patrick
    Thiede, Rebecca
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2024, 65 (03) : 243 - 253
12345